cv 6209 has been researched along with Asthma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, Y; Kurosawa, M; Miyachi, Y; Tsukagoshi, H | 1 |
| Imanishi, N; Morooka, S; Uchida, M | 1 |
| Akutsu, I; Amagai, M; Fukuda, T; Makino, S; Motojima, S; Numao, T | 1 |
3 other study(ies) available for cv 6209 and Asthma
| Article | Year |
|---|---|
CV6209 inhibits airway wall thickening and airway hyperresponsiveness to histamine induced by intravenous administration of platelet-activating factor in guinea pigs.
Topics: Airway Resistance; Animals; Asthma; Bronchi; Guinea Pigs; Histamine; Histamine Antagonists; Lung; Male; Platelet Activating Factor; Pyridinium Compounds | 1996 |
Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine.
Topics: Anaphylaxis; Animals; Asthma; Bronchi; Guinea Pigs; Histamine; Male; Ovalbumin; Platelet Activating Factor; Platelet Count; Pyridinium Compounds; Respiratory Function Tests; SRS-A; Thiazoles; Thiazolidines | 1992 |
[Antigen-induced biphasic eosinophil infiltration in the airways of actively sensitized guinea pigs and its inhibition by PAF antagonist and cyclosporin A].
Topics: Animals; Asthma; Bronchi; Cyclosporins; Eosinophilia; Guinea Pigs; Male; Ovalbumin; Platelet Activating Factor; Pyridinium Compounds; Time | 1990 |